Bridging to liver transplantation patients with a hepatocellular carcinoma within Milan criteria: how worth is it?

The American Association for the Study of the Liver has recently provided conditional recommendations for locoregional ablative therapy to consolidate listing to liver transplantation of patients with a hepatocellular carcinoma (HCC) fulfilling the Milan criteria (MC, OPTN T2), an approach aiming at preventing tumor progression and patients to be delisted accordingly (1).